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Introduction
TMJ arthritis occurs in up to 80% of children with JIA
and it has been described in all JIA subtypes. TMJ
arthritis can develop anytime during the course of JIA,
even when patients are asymptomatic or on biologic
therapy. As it can also occur in the absence of clinically
evident arthritis outside the TMJ, a precocious evalua-
tion by maxillofacial surgery is suggested.
Objectives
Evaluation of TMJ in JIA and presentation of adopted
guidelines in Centro Hospitalar do Porto.
Methods
Selection of three polyarticular JIA cases with TMJ
involvement followed in pediatric rheumatology unit.
The protocol establishes oral-maxillofacial observation
and high-resolution ultrasound at clinical presentation
of polyarticular JIA. The need of contrast-enhanced
magnetic resonance imaging, the periodicity of clinical
observations and the decision to perform intraarticular
corticosteroids injections is based on the clinical reper-
cussion of TMJ arthritis.
Results
Case 1
15 year old girl, with polyarticular JIA diagnosed in 2012
and on etanercept during the past 14 months. The TMJ
response to biologic therapy was minimal and maximal
incisional opening (MIO) was 37mm.Intraarticular
corticosteroid injection (triamcinolone hexacetonide
-1ml; 20mg/ml) was performed and three months after
arthroscopy, pain relief was achieved with a good MIO
improvement.
Case 2
11 year old girl, with psoriatic JIA diagnosed in 2008, on
etanercept during the past 22 months and intolerant to
methotrexat. She has micrognathia, malocclusion of the
teeth with overbite (class 2) and a painful TMJ. Condylar
flattening was observed in the last magnetic resonance
imaging.
Case 3
14 year old girl, with polyarticular JIA diagnosed in 2012
and on etanercept during the past 12 months. Facial
asymmetry and sporadic pain when opening the mouth
were present. TM joint dysfunction with limited left con-
dylar excursion was confirmed in the last high-resolution
ultrasound.
Conclusions
The TMJ involvement in JIA, presented in the cases,
was responsible for the recent creation of a multidisci-
plinary protocol joining pediatric rheumatology and
oral-maxillofacial surgery of Centro Hospitalar do Porto.
The main goal is to guarantee a precocious TMJ exami-
nation, with early treatment when necessary, to avoid
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